Protalix Biotherapeutics, Inc.

291 articles about Protalix Biotherapeutics, Inc.

• Protalix Biotherapeutics Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD

  4/18/2007

• AMEX Lists Common Stock of Protalix Biotherapeutics

  3/12/2007

• Protalix Biotherapeutics to Commence Trading on the AMEX

  3/9/2007

• Orthodontix, Inc. Announces Name Change to Protalix Biotherapeutics

  3/1/2007

• Protalix Biotherapeutics's Board Of Directors Approves The Closing Of The Merger With Orthodontix, Inc.

  12/20/2006

• Orthodontix, Inc. Announces Completion Of Actions Required For Protalix Biotherapeutics Merger

  12/19/2006

• Teva Pharmaceutical Industries Limited And Protalix Biotherapeutics Announce A Collaboration Agreement For The Development Of Two Biopharmaceuticals, Based On Protalix Biotherapeutics's Recombinant Plant Cell Expression Technology

  9/26/2006

• Protalix Biotherapeutics Announces Sale Of Shares

  9/14/2006

• Dr. Philip Frost Leads Up To $21 Million Investment In Protalix Biotherapeutics

  8/23/2006

• The Day In Review: FDA Cancels Meeting For Wyeth Psych Drug

  8/22/2006

• Orthodontix, Inc. And Protalix Biotherapeutics Announce Merger Agreement; $15 Million To Be Invested In Protalix Biotherapeutics

  8/22/2006